Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm

Justin M. Darrah, Mark R. Stefani, Bita Moghaddam

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Behavioral flexibility or 'set-shifting' refers to the ability to modify ongoing behavior in response to changing goals or environmental contingencies. Impaired behavioral flexibility is associated with disorders such as schizophrenia and addiction. Hypofunction of N-methyl-D-aspartate (NMDA) receptors has been implicated in these impairments. Metabotropic glutamate 5 (mGlu5) receptors closely interact with NMDA receptors and may provide a feasible pharmacological target for indirect manipulation of NMDA receptor function in disease states. The aim of this study was to examine the impact of NMDA and mGlu5 receptors on set-shifting ability. We developed a computer-controlled, operant-based set-shifting task that requires rats to learn sequential discrimination rules based on two distinct perceptual dimensions. Using this task, we found that administration of the NMDA receptor antagonist MK801, both systemically and intracortically, significantly impaired task performance, whereas stimulation or inhibition of mGlu5 receptors did not impair task performance. However, when administered after MK801, potentiation of mGlu5 receptor function reduced the performance impairments observed with MK801 alone. These results suggest an interaction between NMDA and mGlu5 receptors in cognitive flexibility and may provide a novel therapeutic approach for treating disorders associated with aberrant NMDA function.

Original languageEnglish (US)
Pages (from-to)225-234
Number of pages10
JournalBehavioural Pharmacology
Volume19
Issue number3
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Metabotropic Glutamate 5 Receptor
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Aptitude
Task Performance and Analysis
Schizophrenia
Pharmacology

Keywords

  • 2-methyl-6-(phenylethynyl)-pyridine
  • 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide
  • Flexibility
  • Medial prefrontal cortex
  • Metabotropic glutamate 5
  • MK801
  • N-methyl-D-aspartate
  • Operant
  • Rat
  • Schizophrenia
  • Set-shifting

ASJC Scopus subject areas

  • Pharmacology
  • Neuroscience(all)

Cite this

Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. / Darrah, Justin M.; Stefani, Mark R.; Moghaddam, Bita.

In: Behavioural Pharmacology, Vol. 19, No. 3, 05.2008, p. 225-234.

Research output: Contribution to journalArticle

@article{3c9140b4184b4780837a00c0628555b8,
title = "Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm",
abstract = "Behavioral flexibility or 'set-shifting' refers to the ability to modify ongoing behavior in response to changing goals or environmental contingencies. Impaired behavioral flexibility is associated with disorders such as schizophrenia and addiction. Hypofunction of N-methyl-D-aspartate (NMDA) receptors has been implicated in these impairments. Metabotropic glutamate 5 (mGlu5) receptors closely interact with NMDA receptors and may provide a feasible pharmacological target for indirect manipulation of NMDA receptor function in disease states. The aim of this study was to examine the impact of NMDA and mGlu5 receptors on set-shifting ability. We developed a computer-controlled, operant-based set-shifting task that requires rats to learn sequential discrimination rules based on two distinct perceptual dimensions. Using this task, we found that administration of the NMDA receptor antagonist MK801, both systemically and intracortically, significantly impaired task performance, whereas stimulation or inhibition of mGlu5 receptors did not impair task performance. However, when administered after MK801, potentiation of mGlu5 receptor function reduced the performance impairments observed with MK801 alone. These results suggest an interaction between NMDA and mGlu5 receptors in cognitive flexibility and may provide a novel therapeutic approach for treating disorders associated with aberrant NMDA function.",
keywords = "2-methyl-6-(phenylethynyl)-pyridine, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide, Flexibility, Medial prefrontal cortex, Metabotropic glutamate 5, MK801, N-methyl-D-aspartate, Operant, Rat, Schizophrenia, Set-shifting",
author = "Darrah, {Justin M.} and Stefani, {Mark R.} and Bita Moghaddam",
year = "2008",
month = "5",
doi = "10.1097/FBP.0b013e3282feb0ac",
language = "English (US)",
volume = "19",
pages = "225--234",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm

AU - Darrah, Justin M.

AU - Stefani, Mark R.

AU - Moghaddam, Bita

PY - 2008/5

Y1 - 2008/5

N2 - Behavioral flexibility or 'set-shifting' refers to the ability to modify ongoing behavior in response to changing goals or environmental contingencies. Impaired behavioral flexibility is associated with disorders such as schizophrenia and addiction. Hypofunction of N-methyl-D-aspartate (NMDA) receptors has been implicated in these impairments. Metabotropic glutamate 5 (mGlu5) receptors closely interact with NMDA receptors and may provide a feasible pharmacological target for indirect manipulation of NMDA receptor function in disease states. The aim of this study was to examine the impact of NMDA and mGlu5 receptors on set-shifting ability. We developed a computer-controlled, operant-based set-shifting task that requires rats to learn sequential discrimination rules based on two distinct perceptual dimensions. Using this task, we found that administration of the NMDA receptor antagonist MK801, both systemically and intracortically, significantly impaired task performance, whereas stimulation or inhibition of mGlu5 receptors did not impair task performance. However, when administered after MK801, potentiation of mGlu5 receptor function reduced the performance impairments observed with MK801 alone. These results suggest an interaction between NMDA and mGlu5 receptors in cognitive flexibility and may provide a novel therapeutic approach for treating disorders associated with aberrant NMDA function.

AB - Behavioral flexibility or 'set-shifting' refers to the ability to modify ongoing behavior in response to changing goals or environmental contingencies. Impaired behavioral flexibility is associated with disorders such as schizophrenia and addiction. Hypofunction of N-methyl-D-aspartate (NMDA) receptors has been implicated in these impairments. Metabotropic glutamate 5 (mGlu5) receptors closely interact with NMDA receptors and may provide a feasible pharmacological target for indirect manipulation of NMDA receptor function in disease states. The aim of this study was to examine the impact of NMDA and mGlu5 receptors on set-shifting ability. We developed a computer-controlled, operant-based set-shifting task that requires rats to learn sequential discrimination rules based on two distinct perceptual dimensions. Using this task, we found that administration of the NMDA receptor antagonist MK801, both systemically and intracortically, significantly impaired task performance, whereas stimulation or inhibition of mGlu5 receptors did not impair task performance. However, when administered after MK801, potentiation of mGlu5 receptor function reduced the performance impairments observed with MK801 alone. These results suggest an interaction between NMDA and mGlu5 receptors in cognitive flexibility and may provide a novel therapeutic approach for treating disorders associated with aberrant NMDA function.

KW - 2-methyl-6-(phenylethynyl)-pyridine

KW - 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide

KW - Flexibility

KW - Medial prefrontal cortex

KW - Metabotropic glutamate 5

KW - MK801

KW - N-methyl-D-aspartate

KW - Operant

KW - Rat

KW - Schizophrenia

KW - Set-shifting

UR - http://www.scopus.com/inward/record.url?scp=43449131567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449131567&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e3282feb0ac

DO - 10.1097/FBP.0b013e3282feb0ac

M3 - Article

C2 - 18469540

AN - SCOPUS:43449131567

VL - 19

SP - 225

EP - 234

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 3

ER -